Real-time enrollment status for this t-cell prolymphocytic leukemia clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 11:51 AM UTC
| NCT Number | NCT04496349 |
| Recruiting Status | Recruiting |
| Condition | T-cell prolymphocytic leukemia |
| Phase | Clinical Trial |
| Target Enrollment | 78 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Ascentage Pharma Group Inc. |
| Last Updated on CT.gov | November 4, 2025 (Nov 4, 2025) |
As of March 2, 2026: Clinical trial NCT04496349 is currently recruiting participants. This clinical trial study for t-cell prolymphocytic leukemia is actively seeking new participants at 3 locations across the United States. The study is sponsored by Ascentage Pharma Group Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04496349 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04496349 was last updated Nov 4, 2025 (November 4, 2025). HelloStudys verifies this status automatically.